These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30642236)

  • 1. From Darkness to Light: Pretargeted Radionuclide Imaging Driven by Tetrazine Bioorthogonal Chemistry.
    Shen G; Liu Z; Bao Y; Kuang A; Wu H
    Curr Top Med Chem; 2018; 18(21):1851-1855. PubMed ID: 30642236
    [No Abstract]   [Full Text] [Related]  

  • 2. From Darkness to Light: Pretargeted Radionuclide Imaging Driven by Tetrazine Bioorthogonal Chemistry.
    Shen G; Liu Z; Ge B; Kuang A; Wu H
    Curr Top Med Chem; 2018; 18(18):1515-1519. PubMed ID: 30543156
    [No Abstract]   [Full Text] [Related]  

  • 3. (99m)Tc-bioorthogonal click chemistry reagent for in vivo pretargeted imaging.
    García MF; Zhang X; Shah M; Newton-Northup J; Cabral P; Cerecetto H; Quinn T
    Bioorg Med Chem; 2016 Mar; 24(6):1209-15. PubMed ID: 26875936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomedical applications of tetrazine cycloadditions.
    Devaraj NK; Weissleder R
    Acc Chem Res; 2011 Sep; 44(9):816-27. PubMed ID: 21627112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, Synthesis, and Evaluation of a Low-Molecular-Weight (11)C-Labeled Tetrazine for Pretargeted PET Imaging Applying Bioorthogonal in Vivo Click Chemistry.
    Denk C; Svatunek D; Mairinger S; Stanek J; Filip T; Matscheko D; Kuntner C; Wanek T; Mikula H
    Bioconjug Chem; 2016 Jul; 27(7):1707-12. PubMed ID: 27308894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretargeting in nuclear imaging and radionuclide therapy: Improving efficacy of theranostics and nanomedicines.
    Stéen EJL; Edem PE; Nørregaard K; Jørgensen JT; Shalgunov V; Kjaer A; Herth MM
    Biomaterials; 2018 Oct; 179():209-245. PubMed ID: 30007471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a (11)C-labeled tetrazine for rapid tetrazine-trans-cyclooctene ligation.
    Herth MM; Andersen VL; Lehel S; Madsen J; Knudsen GM; Kristensen JL
    Chem Commun (Camb); 2013 May; 49(36):3805-7. PubMed ID: 23535705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretargeted Immuno-PET Based on Bioorthogonal Chemistry for Imaging EGFR Positive Colorectal Cancer.
    Shi X; Gao K; Huang H; Gao R
    Bioconjug Chem; 2018 Feb; 29(2):250-254. PubMed ID: 29338219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear medicine theranostics comes of age.
    Herrmann K; Kraus BJ; Hadaschik B; Kunikowska J; van Poppel H; N'Dow J; Sartor O; Oyen WJG
    Lancet Oncol; 2021 Nov; 22(11):1497-1498. PubMed ID: 34735807
    [No Abstract]   [Full Text] [Related]  

  • 10. [Radionuclide teranostic of malignancies].
    Chernov VI; Bragina OD; Sinilkin IG; Medvedeva AA; Zel'chan RV
    Vestn Rentgenol Radiol; 2016; 97(5):306-13. PubMed ID: 30246989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of 1,2,4,5-tetrazine with cationic rhenium(I) polypyridine units to afford phosphorogenic bioorthogonal probes with enhanced reaction kinetics.
    Choi AW; Tso KK; Yim VM; Liu HW; Lo KK
    Chem Commun (Camb); 2015 Feb; 51(16):3442-5. PubMed ID: 25627806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging.
    Reubi JC
    J Nucl Med; 1995 Oct; 36(10):1825-35. PubMed ID: 7562050
    [No Abstract]   [Full Text] [Related]  

  • 13. Diels-Alder reaction for tumor pretargeting: in vivo chemistry can boost tumor radiation dose compared with directly labeled antibody.
    Rossin R; Läppchen T; van den Bosch SM; Laforest R; Robillard MS
    J Nucl Med; 2013 Nov; 54(11):1989-95. PubMed ID: 24092936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frontiers in radionuclide imaging and therapy, a chemical journey from naturally radioactive elements to targeted theranostic agents.
    Casini A; Orvig C; Correia JDG
    Dalton Trans; 2017 Oct; 46(42):14433-14434. PubMed ID: 29057999
    [No Abstract]   [Full Text] [Related]  

  • 15. Alkene-tetrazine ligation for imaging cellular DNA.
    Rieder U; Luedtke NW
    Angew Chem Int Ed Engl; 2014 Aug; 53(35):9168-72. PubMed ID: 24981416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harnessing the bioorthogonal inverse electron demand Diels-Alder cycloaddition for pretargeted PET imaging.
    Reiner T; Lewis JS; Zeglis BM
    J Vis Exp; 2015 Feb; (96):e52335. PubMed ID: 25742199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of Affibody-Based Bioorthogonal Chemistry-Mediated Radionuclide Pretargeting.
    Altai M; Perols A; Tsourma M; Mitran B; Honarvar H; Robillard M; Rossin R; ten Hoeve W; Lubberink M; Orlova A; Karlström AE; Tolmachev V
    J Nucl Med; 2016 Mar; 57(3):431-6. PubMed ID: 26659353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immune scintigraphy with monoclonal antibodies. Experiences and prospects].
    Munz DL
    Dtsch Med Wochenschr; 1987 Apr; 112(16):649-54. PubMed ID: 3552549
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiotracer chemistry in 2002.
    Fowler JS
    J Nucl Med; 2003 Jan; 44(1):19N-22N. PubMed ID: 12524695
    [No Abstract]   [Full Text] [Related]  

  • 20. A 99mTc-Labelled Tetrazine for Bioorthogonal Chemistry. Synthesis and Biodistribution Studies with Small Molecule trans-Cyclooctene Derivatives.
    Vito A; Alarabi H; Czorny S; Beiraghi O; Kent J; Janzen N; Genady AR; Al-Karmi SA; Rathmann S; Naperstkow Z; Blacker M; Llano L; Berti PJ; Valliant JF
    PLoS One; 2016; 11(12):e0167425. PubMed ID: 27936007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.